In this continuation of a three-part series, the author explores the potential use of agentic AI in pharmaceutical R&D.

MasterControl research shows 40% of advanced therapy executives aren't confident they can meet CGT demand over the next three ...

Healthcare AI startup dHealth Intelligence just unveiled an AI agent that consolidates fragmented medical data & provides ...

THX Pharma is entering a new strategic phase focused on regulatory approval, early access, and international commercialization of its medicines. Lyon, France - September 29 ...

Partnerships are also critical. Many small biotechs deploy CROs to assist with trials, and Conga’s platform allows these ...

The lawsuit, which seeks class-action status on behalf of gun owners nationwide, was filed in U.S. District Court in ...

Abivax Announces Acceptance of Additional Late-Breaking Abstract from the ABTECT Phase 3 Induction Trials to be Presented at 2025 United European ...

Brown & Company’s digital arm, Browns IT was recently awarded the ISO 9001:2015 certification by world-leading certification ...

The complex regulatory landscape for biological drug products presents opportunities in mastering Chemistry, Manufacturing, and Controls (CMC) requirements, especially for varying molecule types. This ...

There’s nothing more exasperating for the state’s taxpayers than evidence of widespread fraud in the welfare and health-care ...

The US Department of State’s 2025 Investment Climate Statement reveals Morocco’s strategic efforts to establish itself as a ...

Transportation Management Systems (TMS) have become foundational to building resilient, cost-optimized, and transparent ...